Cargando…
Outcomes for localized treatment of large cell neuroendocrine carcinoma of the lung in the United States
BACKGROUND: Treatment paradigms for large cell neuroendocrine carcinoma (LCNEC) of the lung are based largely upon small retrospective studies and smaller prospective trials. It is unclear if these tumors behave like non-small cell lung cancer (NSCLC) or small cell lung cancer (SCLC). Data are lacki...
Autores principales: | May, Michael S., Kinslow, Connor J., Adams, Christopher, Saqi, Anjali, Shu, Catherine A., Chaudhary, Kunal R., Wang, Tony J. C., Cheng, Simon K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7867769/ https://www.ncbi.nlm.nih.gov/pubmed/33569294 http://dx.doi.org/10.21037/tlcr-20-374 |
Ejemplares similares
-
Prevalence of Estrogen Receptor Alpha (ESR1) Somatic Mutations in Breast Cancer
por: Kinslow, Connor J, et al.
Publicado: (2022) -
NRF2-pathway mutations predict radioresistance in non-small cell lung cancer
por: Kinslow, Connor J., et al.
Publicado: (2022) -
Smurf2 inhibition enhances chemotherapy and radiation sensitivity in non-small-cell lung cancer
por: Chaudhary, Kunal R., et al.
Publicado: (2022) -
Hepatoid Adenocarcinoma of the Lung Responsive to Frontline Combination Chemotherapy With Immunotherapy: Case Report
por: Lagos, Galina G., et al.
Publicado: (2020) -
Incidence and Survival Outcomes in Patients with Lung Neuroendocrine Neoplasms in the United States
por: Shah, Shrunjal, et al.
Publicado: (2021)